Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to diseaseRoberto Bomprezzi, Jeffrey M. Trent, Markus Ringnér et al.|Human Molecular Genetics|2003Cited by 216
The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromasAlexander Pemov, Douglas R. Stewart, H Li et al.|Oncogene|2017Cited by 119
PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideShumpei Onishi, Yeshavanth Banasavadi‐Siddegowda, Ashish H. Shah et al.|Research Square|2025Cited by 1
DDDR-02. PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideShumpei Onishi, Yeshavanth Banasavadi‐Siddegowda, Sridharan Jayamohan et al.|Neuro-Oncology|2025Cited by 1